LegalJun 11, 2026, 02:01 PM
Regenerex Pharma Sues Former CFO for Fraud and Misappropriation
AI Summary
Regenerex Pharma, Inc. has commenced legal proceedings against its former Chief Financial Officer, Kenneth W. Perry. The company alleges that Perry engaged in a scheme to manipulate financial records, caused unauthorized payroll overpayments totaling approximately $55,200, and improperly inflated invoices from a related company, Optimize Health Partners, LLC, by about $37,285. Additionally, the lawsuit claims Perry unauthorizedly issued 25,000 shares of company stock and engaged in coercive behavior. Regenerex is seeking recovery of funds, damages, and other relief.
Key Highlights
- Regenerex Pharma is suing former CFO Kenneth W. Perry for recovery of funds and other amounts owed.
- The lawsuit alleges unauthorized payroll overpayments totaling approximately $55,200.
- Perry is accused of inflating invoices for software development by approximately $37,285.23 through a 30% administrative fee.
- The company alleges Perry improperly authorized the issuance of 25,000 shares of common stock to the 'Adriana Natasha Perry Trust'.
- Regenerex claims Perry engaged in extortionate and coercive conduct, demanding a separation agreement under threat of adverse consequences.
- The lawsuit includes counts for conversion, fraudulent inducement, civil theft, breach of fiduciary duty, tortious interference, civil extortion, destruction of records, negligence, and unjust enrichment.
Price Impact
More from RGPX